Volume 76; 2024 Aug

Reviews

The impact of age on physical functioning after treatment for breast cancer, as measured by patient-reported outcome measures: A systematic review

V.R. Robins, S. Gelcich, K. Absolom, G. Velikova

Breast. 2024 Aug; 76: 103734. Published online 2024 Apr 18. doi: 10.1016/j.breast.2024.103734

PMCID:: PMC11070762

Abstract Article PDF–1.0M

Diagnostic accuracy of intraoperative methods for margin assessment in breast cancer surgery: A systematic review & meta-analysis

Gavin P. Dowling, Cian M. Hehir, Gordon R. Daly, Sandra Hembrecht, Stephen Keelan, Katie Giblin, Maen M. Alrawashdeh, Fiona Boland, Arnold D.K. Hill

Breast. 2024 Aug; 76: 103749. Published online 2024 May 10. doi: 10.1016/j.breast.2024.103749

PMCID:: PMC11127275

Abstract Article PDF–2.5M

Original Articles

Prediction of breast cancer and axillary positive-node response to neoadjuvant chemotherapy based on multi-parametric magnetic resonance imaging radiomics models

Yingyu Lin, Jifei Wang, Meizhi Li, Chunxiang Zhou, Yangling Hu, Mengyi Wang, Xiaoling Zhang

Breast. 2024 Aug; 76: 103737. Published online 2024 Apr 24. doi: 10.1016/j.breast.2024.103737

PMCID:: PMC11070644

Abstract Article PDF–5.7M

Early evaluation of circulating tumor DNA as marker of therapeutic efficacy and prognosis in breast cancer patients during primary systemic therapy

Ru Wang, Bin Wang, Huimin Zhang, Xiaoqin Liao, Bohui Shi, Yuhui Zhou, Can Zhou, Yu Yan, Wei Zhang, Ke Wang, Guanqun Ge, Yu Ren, Xiaojiang Tang, Baoyu Gan, Jianjun He, Ligang Niu

Breast. 2024 Aug; 76: 103738. Published online 2024 Apr 24. doi: 10.1016/j.breast.2024.103738

PMCID:: PMC11067540

Abstract Article PDF–6.6M

Invasive lobular carcinoma of the breast; clinicopathologic profile and response to neoadjuvant chemotherapy over a 15-year period

N.P. Quirke, C. Cullinane, M.A. Turk, N. Shafique, D. Evoy, J. Geraghty, D. McCartan, C. Quinn, J.M. Walshe, E. McDermott, C. Rutherford, R.S. Prichard

Breast. 2024 Aug; 76: 103739. Published online 2024 May 1. doi: 10.1016/j.breast.2024.103739

PMCID:: PMC11126855

Abstract Article PDF–814K

Screening optimal candidates with operable, early-stage triple-negative breast cancer benefitting from capecitabine maintenance: A post-hoc analysis of the SYSUCC-001 study

Fangfang Duan, Xin Hua, Xiwen Bi, Shusen Wang, Yanxia Shi, Fei Xu, Li Wang, Jiajia Huang, Zhongyu Yuan, Yuanyuan Huang, South China Breast Cancer Group (SCBCG)

Breast. 2024 Aug; 76: 103740. Published online 2024 May 6. doi: 10.1016/j.breast.2024.103740